Quest Diagnostics (DGX) Tops Q4 EPS by 4c; Guides Above the Street

Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.08, $0.04 better than the analyst estimate of $1.04. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.85 billion.

Quest Diagnostics sees FY2015 EPS of $4.70-$4.85, versus the consensus of $4.43. Revenues to increase approximately 2% to 3%, compared to 2014.

"We ended 2014 strong, and in the fourth quarter generated growth in revenues and EPS," said Steve Rusckowski, President and CEO. "The 2015 outlook we are providing today is based on our expectations for strengthening operational performance and an improving business environment. Further, based on our ability to continue to generate strong cash flow, today we are announcing the fourth increase in our dividend since 2011."

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Aeroméxico Announces Webcast of Second Quarter 2026 Financial Results
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance